Annex

The Annexes to Regulation (EEC) No 2377/90 are hereby amended as follows:

1. A..

   Annex I is amended as follows:

   1. 2..

      Antiparasitic agents

      1. 2.1.

         Agents acting against endoparasites

         1. 2.1.3.

            Benzimidazoles and pro-benzoimidazoles

            Pharmacologically active substance	Marker residue	Animal species	MRLs	Target tissues	Other provisions
            ‘2.1.3.1. Febantel	Sum of extractable residues which may be oxidized to oxfendazole sulphone	Bovine, ovine, porcine, equidae	50 μg/kg	Muscle
            			50 μg/kg	Fat
            			500 μg/kg	Liver
            			50 μg/kg	Kidney
            		Bovine, ovine	10 μg/kg	Milk
            2.1.3.2. Fenbendazole	Sum of extractable residues which may be oxidized to oxfendazole sulphone	Bovine, ovine, porcine, equidae	50 μg/kg	Muscle
            			50 μg/kg	Fat
            			500 μg/kg	Liver
            			50 μg/kg	Kidney
            		Bovine, ovine	10 μg/kg	Milk
            2.1.3.3. Oxfendazole	Sum of extractable residues which may be oxidized to oxfendazole sulphone	Bovine, ovine, porcine, equidae	50 μg/kg	Muscle
            			50 μg/kg	Fat
            			500 μg/kg	Liver
            			50 μg/kg	Kidney
            		Bovine, ovine	10 μg/kg	Milk’

   2. 5..

      Corticoids

      1. 5.1.

         Glucocorticoids

         Pharmacologically active substance	Marker residue	Animal species	MRLs	Target tissues	Other provisions
         ‘5.1.1. Dexamethasone	Dexamethasone	Bovine, porcine, equidae	0,75 μg/kg	Muscle
         			2,0 μg/kg	Liver
         			0,75 μg/kg	Kidney
         		Bovine	0,3 μg/kg	Milk’

2. B..

   Annex II is amended as follows:

   1. 1..

      Inorganic compounds

      Pharmacologically active substance(s)	Animal species	Other provisions
      ‘1.29. Bromide, sodium salt	All food producing mammals	For topical use only’

3. C..

   Annex III is amended as follows:

   1. 1..

      Anti-infectious agents

      1. 1.2.

         Antibiotics

         1. 1.2.4.

            Cephalosporins

            Pharmacologically active substance	Marker residue	Animal species	MRLs	Target tissues	Other provisions
            ‘1.2.4.1. Ceftiofur	Sum of all residues retaining the betalactam structure expressed as desfuroylceftiofur	Bovine	2 000 μg/kg	Liver, kidney	200 μg/kg
            			Muscle	600 μg/kg
            			Fat	100 μg/kg
            			Milk	Provisional MRLs expire on 1. 1. 1999’
            		Porcine	4 000 μg/kg	Kidney
            			3 000 μg/kg	Liver
            			500 μg/kg	Muscle
            			600 μg/kg	Fat

      2. 1.2.6.

         Quinolones

         Pharmacologically active substance	Marker residue	Animal species	MRLs	Target tissues	Other provisions
         ‘1.2.6.1. Danofloxacin	Danofloxacin	Bovine	900 μg/kg	Liver	500 μg/kg
         			Kidney	300 μg/kg
         			Muscle	200 μg/kg
         			Fat	Provisional MRLs expire on 1. 1. 1999’
         		Chicken	1 200 μg/kg	Liver, kidney
         			600 μg/kg	Skin + fat
         			300 μg/kg	Muscle

   2. 2..

      Antiparasitic agents

      1. 2.1.

         Agents acting against endo-parasites

         1. 2.1.1.

            Benzimidazoles and pro-benzoimidazoles

            Pharmacologically active substance	Marker residue	Animal species	MRLs	Target tissues	Other provisions
            ‘2.1.1.9. Netobimin	Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino-benzimidazole sulphone	Bovine, ovine, caprine	100 μg/kg	Muscle, fat	Provisional MRLs expire on 31. 7. 1999’
            			1 000 μg/kg	Liver
            			500 μg/kg	Kidney
            			100 μg/kg	Milk